Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report

BMC Med Genomics. 2023 Aug 12;16(1):186. doi: 10.1186/s12920-023-01622-8.

Abstract

Background: Xeroderma pigmentosum group E (XP-E) is one of the least common forms of XP, a rare syndrome where patients are prone to develop skin cancer in exposed sunlight areas. XP-E patients are generally not diagnosed until they are adults due to the mild phenotype.

Case presentation: two XP-E siblings, female, 23 years, and male, 25 years, from a Brazilian consanguineous family carrying the novel missense pathogenic variant in DDB2 gene, NM_000107.3:c.1027G > C, associated with skin cancer early-onset and severe phenotype, as nodular melanoma in the cornea and in the ear.

Conclusion: The assessment of genomic variant pathogenicity was a challenge since this family belongs to an underrepresented population in genomic databases. Given the scarcity of literature documenting XP-E cases and the challenges encountered in achieving an early diagnosis, this report emphasizes the imperative of sun protection measures in XP-E patients. Additionally, it highlights the detrimental impact of the COVID-19 pandemic on cancer diagnosis, leading to the manifestation of a severe phenotype in affected individuals.

Keywords: Case Report; Melanoma; XP-E; Xeroderma Pigmentosum.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brazil
  • COVID-19* / epidemiology
  • DNA Repair
  • DNA-Binding Proteins / genetics
  • Female
  • Humans
  • Male
  • Melanoma* / genetics
  • Pandemics
  • Siblings
  • Skin Neoplasms* / genetics
  • Xeroderma Pigmentosum* / epidemiology
  • Xeroderma Pigmentosum* / genetics
  • Xeroderma Pigmentosum* / pathology

Substances

  • DDB2 protein, human
  • DNA-Binding Proteins

Supplementary concepts

  • Xeroderma Pigmentosum, Complementation Group E